WATSON PHARMACEUTICALS (NYSE: WPI)

View Portfolio
Back to Investopedia
Back to Investopedia




$38.10 0.41 (1.09%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
42.50
52-Week Low Price
25.31
Avg Volume (3 Mo.)
1.00 M
Market Cap
4.00 B
P/E Ratio (TTM)
19.5
Diluted EPS (TTM)
2.56
Shares
106.14 M
Dividend Rate ($) / (%)
0.00/0.00
76%
24%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 37% - WPI has outperformed the S&P 500 by 11%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
CEPHALON INC (CEPH) $65.78 -  $0.78(1.20%)4.81 B
QIAGEN NV (QGEN) $20.60 -  $0.06(0.29%)4.81 B
HUMAN GENOME SCIENCES (HGSI) $27.06 -  $1.30(5.05%)4.41 B
PERRIGO CO (PRGO) $46.32 -  $0.58(1.27%)4.13 B
ALEXION PHARMACEUTICALS (ALXN) $46.91 -  $0.94(2.04%)4.14 B
DR REDDY'S LAB LTD ADS (RDY) $23.66 -  $0.32(1.37%)4.07 B
DENDREON CORP (DNDN) $29.44 -  $0.55(1.90%)3.33 B
ELAN CORP PLC (ELN) $7.07 -  $0.10(1.43%)3.37 B
UNITED THERAPEUTICS CORP (UTHR) $58.63 -  $1.34(2.34%)3.07 B
IDEXX LABORATORIES INC (IDXX) $50.56 -  $0.57(1.14%)2.93 B
As of February 09, 2010 at 6:45 PM ET
STOCK ANALYSIS
Stock Analysis
There's Nothing Generic About the Profits (TEVA, WPI)
Any healthcare reform will include severe cost cutting. Giving your portfolio a dose of generic-dug makers will hel...
Stock Analysis
Meet Teva, The Generic Giant
Success in generic drugs is all about high volume, low prices and global presence. Israel's Teva Pharmaceuticals h...
Stock Analysis
Buyout Or Sellout Time At Biovail
Troubled drugmaker Biovail could be in play as Eugene Melnyk said he'll either sell his 11% stake or take the compa...
Stock Analysis
Testing Generic Drug Makers (BRL, WPI, PRX)
We examine the business models of three generic drug manufacturers to discover which will work best for your portfo...
Stock Analysis
Biovail's Woes Crawl From The Woodwork (BVF)
With legal issues and pressure from generic drug manufacturers, drug company Biovail's prospects don't look good.
View All Stock Analysis
WPI RELATED HEADLINES
arrow
There's Nothing Generic About the Profits (TEVA, WPI)
Any healthcare reform will include severe cost cutting. Giving your portfolio a dose of generic-dug makers will help you profit from the changes.
at Investopedia Advisor 1/27/2010
arrow
Watson Pharmaceutical (WPI) NewsBite - WPI Downgraded By Needham
Watson Pharmaceutical (WPI) was downgraded today by analysts at Needham and the stock is now at $40.06, down $0.35 (-0.87%) on volume of 717,252 shares traded. The analysts cut WPI to Underperform from Hold. Over the last 52 weeks the stock has ranged from a low of $23.97 to a high of $42.50. Watson Pharmaceutical stock has been showing support around $39.70 a...
At Market Intelligence Center 1/22/2010
arrow
StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc.
StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc.
by GlobeNewswire 11/18/2009
arrow
Watson Pharmaceutical (WPI) NewsBite - WPI Is On the Move
Watson Pharmaceutical (WPI) appears to be on the move today and is now at $36.87, down $0.82 (-2.16%) on volume of 669,998 shares traded. Over the last 52 weeks the stock has ranged from a low of $20.19 to a high of $38.48. Watson Pharmaceutical stock has been showing support around $36.88 and resistance in the $38.88 range....
At Market Intelligence Center 10/19/2009
arrow
Beacon Equity Issues Trading Overview for Keryx Biopharmaceuticals
Beacon Equity Issues Trading Overview for Keryx Biopharmaceuticals
by GlobeNewswire 10/15/2009
arrow
Beacon Equity issues Trading Outlook for Cannabis Science Inc.
Beacon Equity issues Trading Outlook for Cannabis Science Inc.
by GlobeNewswire 7/30/2009
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1